Patent · US Expired

Monoclonal antibodies against a human act and serine protease complex

US6630350B1 · kind B1 · utility

0Cited by

2References

1Claims

0Family size

Assignee

Roche Diagnostics GMBH · DE

Inventors

Christa Hubner-Parajsz · Tutzing, DE
Hartmut Schetters · Neufahrn, DE
Rosemarie Kientsch-Engel · Feldafing, DE
Thomas Meier · Cherbourg, FR
Martin Kaufmann · Weilheim, DE
Andreas Gallusser · Penzberg, DE
Rolf Deeg · Seeshaupt, DE

Key dates

Filing date	Sep 3, 1999
Grant date	Oct 7, 2003
Priority date	—
Expiry date	Sep 3, 2019

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/57434
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention concerns monoclonal antibodies against a complex of human ACT and a serine protease, preferably against a ACT-PSA, which have essentially no cross-reactivity with free, non-complexed human ACT and with free, non-complexed PSA, as well as diagnostic test methods for detecting serine protease-ACT complexes, in particular PSA-ACT, using these monoclonal antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.